After the rewarding experience in the past two annuals of the TTS Global Initiative in Medellín and Santiago de Compostela, BioSeed Capital took part in the latest conference as part of the international speakers.

Juan R. García, managing partner at the Biotechnology Business Institute and BioSeed Capital, traveled to Miami last 28th of November for the last TTS Global Initiative conference. In this occasion, the second annual concerning Latin American countries gathered stakeholder groups from all over the globe dated in search of an effective relationship between the main actors involved in the pharmaceutical and biotechnology industry.

New this year, there was a great focus on networking and building business relations between the main actors of the between the top institutions and early-stage biotech companies in Latin America, and leading US and European TTOs, institutions, investors, entrepreneurs, pharma, large biotech and industry.

Once again, BioSeed Capital was invited to take part in the conference, after the rewarding experience lived in the past two annuals of the TTS Global Initiative, held in Medellín, Colombia – TTS Latin America – and Santiago the Compostela – TTS Europe – during 2016 and 2017 respectively. Our Chairman, Juan R. García, was one of the international speakers that talked about the biotech start-up funding and SMEs in Latin America. García explained during the panel discussion what the investors are looking for in this growing sector of life sciences.

Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filter by category